我是CPAP用户；多久需要做一次新的睡眠研究？

There is no fixed routine repeat schedule for asymptomatic adherent patients. Repeat testing is indicated when there is meaningful weight change (10 percent or more), new symptoms, device-type changes, persistent intolerance, or before alternative treatments such as Inspire therapy. Some insurance plans require periodic re-evaluation for continued coverage.

Possibly. A 10 percent body-weight reduction is associated with average AHI reduction of about 26 percent based on cohort data, which may allow a lower therapeutic pressure or, in some cases, allow discontinuation of PAP entirely. A repeat sleep study is the only way to confirm the new pressure requirement.

Often, yes. Most insurance plans require documented CPAP failure plus a titration study identifying appropriate BiPAP pressures. Some payers accept a clinical trial without re-titration; check your specific plan rules with your sleep physician and DME provider.

Recurrent symptoms despite documented adherence can indicate residual OSA at the current pressure setting, a new contributor (weight gain, alcohol use, sedating medications), or a non-OSA sleep disorder (periodic limb movements, depression, idiopathic hypersomnia). Discuss with your sleep physician; repeat testing may be appropriate.

Medicare requires periodic re-evaluation rather than fixed repeat testing -- specifically, an annual physician visit to confirm continued benefit from PAP therapy. Repeat sleep testing is required only when there is a clinical reason (weight change, new symptoms, device-type change).